Samsung investing big in biopharmaceuticals, AI, chips, robotics
SEOUL (Reuters) -Samsung Group will invest 240 trillion won ($206 billion) in the next three years to expand its footprint in biopharmaceuticals, artificial intelligence, semiconductors and robotics in the post-pandemic era, Samsung Electronics Co Ltd said. Samsung Electronics, the world’s largest memory chip maker, said the group plans to solidify technology and market leadership through mergers and acquisitions. Samsung Group has 59 affiliates with assets totalling 457 trillion won, according to South Korea’s Fair Trade Commission. The investment plan comes just over a week since Samsung...